5 News & Press Releases found

LenioBio GmbH news

Revolutionizing Biopharma manufacturing

LenioBio develops efficient and sustainable technologies for protein expression. Company with a clear goal: To simplify protein production and accelerate the delivery of drugs to patients.

Revolutionizing Biopharma manufacturing LenioBio develops efficient and sustainable technologies for protein expression. Company with a clear goal: To simplify protein production and accelerate the delivery of drugs to patients. emberto Martis first came across the cell-free protein expression te

Feb. 3, 2023

A breakthrough in biopharmaceutical protein production; LenioBio announces a new proprietary cell line devoid of plant glycans.

Dusseldorf, May 16, 2022 – the German life science biotech firm, LenioBio GmbH, today announced the generation of a novel plant glycan knockout cell line that will increase the versatility and flexibility of the company’s cell-free protein synthesis (CFPS) system, ALiCE®.

LenioBio’s proprietary ALiCE® platform is derived from a tobacco BY-2 plant cell lysate. Plant-based expression systems are ideal biofactories for

May. 15, 2022

LenioBio closes its Series-A Extension round and strengthens its Board of Directors.

LenioBio GmbH, a German life sciences biotech offering a disruptive protein manufacturing technology, ALiCE®, closed its Series-A Extension round with a total investment volume of €11.5 million. The investment round, which was closed in November 2021, is led by LenioBio`s current investor Bridford Group, a PE investor focusing on founder-led businesses with long-term growth potential and concerned with societal or envir

Mar. 6, 2022

LenioBio GmbH announces the appointment of Dr. Dorothee Ambrosius to LenioBio’s Scientific Advisory Board.

Dusseldorf, December 22, 2021 – LenioBio GmbH, a German life science biotech offering a disruptive protein manufacturing technology, ALiCE®, announces the appointment of Dr. Dorothee Ambrosius to LenioBio’s Scientific Advisory Board.

“We are thrilled to have such an expert as Dr. Dorothee Ambrosius joining our SAB” said Dr. Ricarda Finnern, CSO of LenioBio. “Dr. Ambrosius brings years of experience in developing bioprocess

Dec. 21, 2021

LenioBio Announces a Scientific Advisory Board Composed of Experts within the Field of Biotechnology

DUSSELDORF, Germany, February 14, 2019 – LenioBio GmbH announces the appointment of Dr. Lorenz M. Mayr, Prof. Govind Rao, and Prof. Stefan Schillberg to LenioBio’s Scientific Advisory Board (SAB). LenioBio is a German life sciences start-up dedicated to the advancement of a transformative technology for the discovery, development, and expression of ‘difficult-to-produce’ proteins unconstrained by the limitations of the cell.

“We

Feb. 14, 2019